Pretreatment with tumor necrosis factor-α attenuates arterial hypotension and mortality induced by endotoxin in pigs
- 1 June 2000
- journal article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 28 (6) , 2015-2021
- https://doi.org/10.1097/00003246-200006000-00056
Abstract
Tumor necrosis factor (TNF)-alpha administration in large amounts can induce a state of shock similar to that seen during severe sepsis. The objective of this study was to determine whether small doses of TNF-alpha might decrease the disposition for the development of shock induced by a subsequent infusion of endotoxin and to determine whether the mechanism of this protective effect of TNF-alpha pretreatment could be associated with up-regulation of the anti-inflammatory cytokine interleukin (IL)-10. Prospective, randomized, experimental study. Investigative intensive care unit at an academic medical center. A total of 14 female Yorkshire pigs, weighing 20-25 kg. We studied two groups of animals-pigs treated with 500 ng/kg recombinant porcine TNF-alpha (n = 7) and pigs given diluent alone (n = 7). At 24 hrs after treatment, both groups of pigs were subjected to a 24-hr continuous infusion of lipopolysaccharide (LPS) at a rate of 80 ng/kg/min. The mortality rate was determined in both groups. Hemodynamic indices, oxygen transport variables, total and differential white cell counts, and serum concentrations of TNF and IL-10 were determined at frequent intervals before and after TNF-alpha administration and during the LPS infusion. Additionally, peripheral blood mononuclear cells were collected for determination of messenger ribonucleic acid expression of IL-10 by reverse transcription-polymerase chain reaction. The administration of TNF-alpha at the dose used in this study did not have any profound effect. No pig treated with TNF-alpha died in response to the LPS infusion. In contrast, three of seven control pigs died during the LPS infusion. Lipopolysaccharide-induced arterial hypotension and arterial hypoxemia were attenuated in the TNF-alpha-treated group. Both groups had significant increases in serum concentrations of TNF-alpha in response to LPS, with no significant difference in peak serum TNF-alpha between groups. Neither serum concentrations of IL-10 nor expression of IL-10 messenger ribonucleic acid in circulating mononuclear cells differed between groups. The administration of TNF-alpha attenuated the severity of hyperdynamic shock induced by a subsequent infusion of endotoxin. This effect could not be associated with increased expression or elaboration of the anti-inflammatory cytokine IL-10.Keywords
This publication has 62 references indexed in Scilit:
- Pattern of soluble TNF receptors I and II in sepsisInfection, 1995
- Two inhibitors of pro‐inflammatory cytokine release, interleukin‐10 and interleukin‐4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytesEuropean Journal of Immunology, 1994
- Relationships between plasma cytokine concentrations and leukocyte functional antigen expression in patients with sepsisCritical Care Medicine, 1994
- Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation.The Journal of Experimental Medicine, 1994
- Increased plasma concentrations of soluble tumor necrosis factor receptors in sepsis syndromeCritical Care Medicine, 1994
- Prognostic values of serum cytokines in septic shockIntensive Care Medicine, 1994
- Neutrophils contribute to TNF induced myocardial tolerance to ischaemiaJournal of Molecular and Cellular Cardiology, 1992
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.The Journal of Experimental Medicine, 1991
- The Cardiovascular Response of Normal Humans to the Administration of EndotoxinNew England Journal of Medicine, 1989
- Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock.The Journal of Experimental Medicine, 1989